Clinical trial

Inhaled Steroid Reduces Systemic Inflammation in COPD

NCT00175565

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-01-01

PhasePHASE4

Study timeline

Study start (unknown)2002-01-01Date precision: month

Registry last updated2010-07-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseverified · MONDO: chronic obstructive pulmonary disease

Emphysemaverified · MONDO: pulmonary emphysema

Chronic Bronchitisverified · MONDO: chronic bronchitis

Interventions

inhaled fluticasone 500 mcg b.i.d.DRUG

Sponsors & collaborators

University of British Columbialead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

VancouverBritish Columbia, Canada1 EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00175565 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.